MedTechLabs labs interview with Stratipath CEO, Fredrik Wetterhall,
MedTechLabs labs recently interviewed our CEO, Fredrik Wetterhall, discussing the rapid development from research to clinical use and the future trajectory of Stratipath.
Stratipath is proud to be a part of Proscia’s new partner alliance ”Proscia Ready”
Stratipath is proud to be a part of Proscia’s new partner alliance ”Proscia Ready”.
”Inside Pathology” by Paige features Stratipath co-workers
”Inside Pathology” by Paige features Stratipath co-workers
Stratipath is now a part of Paige AppLab
Stratipath is now a part of Paige AppLab
Stratipath and Proscia Partnership Spotlighted in Pathology News
Stratipath and Proscia Partnership Spotlighted in Pathology News
Stratipath And Proscia Announce Partnership, Paving The Way To Bring Relapse Risk Prediction To More Breast Cancer Patients
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and Proscia®, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.
Stratipath secures its position on the esteemed startup list for the second consecutive year.
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and Proscia®, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.
Webinar with the Swedish Breast Cancer association
Stratipath co-founder and Chief Medical Officer Johan Hartman, was participating in a webinar hosted by the Swedish Breast Cancer Association (Bröstcancerförbundet) to discuss the impact of AI in breast cancer care.
Stratipath co-founders, Mattias Rantalainen and Johan Hartman are receiving the prestigious Karolinska Institutet’s award for innovation and utilisation.
Stratipath, a global leader in artificial intelligence (AI)-based precision diagnostic solutions, and Proscia®, a leading provider of digital and computational pathology solutions, have partnered to help oncologists and pathologists determine the most suitable treatment path for more breast cancer patients.
”AI can be a game-changer” An exclusive interview featuring Stratipath co-founder Johan Hartman in the Swedish wellness magazine ”Må Bra”
More people are living longer with breast cancer – AI can be a game-changer.As October marks Breast Cancer Awareness Month, “Må Bra,” the Swedish wellness magazine, initiates this significant month with an exclusive interview featuring Stratipath co-founder Johan Hartman. The interview delves into topics such as groundbreaking treatments, precision medicine, and the game-changing potential of AI-powered […]
